IbogaineAdvisor.
About All articles
Perspectives: Voices and Views

The people inside it. The arguments around it.

Two kinds of content live here: profiles of the people ibogaine actually happened to, and editorial pieces that take on the harder questions the rest of the space tends to sidestep.

Patient and practitioner profiles are verified and reviewed by the subject before publication. Nothing goes out without their sign-off.
Analysis pieces represent the author's view and are labeled clearly. We don't dress up argument as reporting.
We don't romanticize outcomes or paper over complexity. Both the profiles and the analysis pieces are honest about what this thing is.
No financial relationship with any clinic. Profiles and analysiss are independent of the directory.
Views
Analysis · Eric Bozinny

What the Ambio Death Actually Tells Us About Ibogaine’s Real Risk Profile

A patient died at Ambio Life Sciences in January 2026. Ambio told the public about it. The details deserve more attention than they got — especially the fentanyl variable most coverage missed.

June 1, 2026 · 6 min read Read →
Views · Eric Bozinny

Whom Do We Owe? The Iboga Reciprocity Question Doesn’t Have a Clean Answer

Do Western ibogaine clinics owe something to the Bwiti? The instinct that something is owed is pointing at something real. The history of who owned what, and when, is considerably messier.

May 13, 2026 · 9 min read Read →
Voices
The Mother

Diane Hall

She opened an Instagram account for one reason: to find the thing that might still save her son. After a decade of rehabs that did not hold, the answer came back from a stranger she had never met.

Published Read profile →

More voices coming.

Ibogaine touches everyone differently. These profiles are planned: stories across the full range of who seeks this treatment, and why — and what they found on the other side.

New profiles as they publish.

IbogaineAdvisor adds new Perspectives profiles as interviews complete. Subscribe and you'll hear when the next one is live.